tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Stock Investors

Compare
473 Followers
Based on 798,340 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold URGN
On average, investors allocate 3.24% of their portfolios to URGN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 798,340 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding URGN

1.5%
Last 7
Days
1.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding URGN, out of 798,340 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

URGN Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.11%
$11.55
Based on the activity of investors who made their portfolios public
The table shows changes in URGN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

URGN Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.90%
-0.18%
+0.65%
3.03B
Healthcare
Nio
8.58%
-0.40%
-1.69%
7.97B
Consumer Cyclical
JD
4.71%
<+0.01%
-0.45%
48.64B
Consumer Cyclical
CVS Health
4.24%
+0.73%
+3.70%
83.78B
Healthcare
Delta Air Lines
4.56%
-0.49%
+0.19%
29.26B
Industrials
Riot Platforms
4.52%
+1.57%
+1.10%
2.81B
Financial
Bristol Myers
3.21%
-0.27%
-0.52%
96.81B
Healthcare
Block
3.38%
+0.42%
+1.88%
29.09B
Technology
Merck & Company
3.00%
-1.03%
+1.32%
198.47B
Healthcare
PDD Holdings
4.76%
-0.84%
-1.52%
154.97B
Consumer Cyclical
Based on the activity of 798,340 active portfolios
Open your Smart Portfolio

URGN Investor Analysis

URGN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.3%
of URGN holders
are under 35
Average Segment Performance
Average P/E Ratio16.96
Beta4.77
Dividend Yield4.15%
URGN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
47.1%
of URGN holders
are between 35–55
Average Segment Performance
Average P/E Ratio14.90
Beta12.49
Dividend Yield3.55%
URGN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
42.6%
of URGN holders
are over 55
Average Segment Performance
Average P/E Ratio10.82
Beta6.97
Dividend Yield3.85%
Overview of age group and performance of URGN stock investors
See who invests in URGN according to age group and performance.

FAQ

How many retail Investors hold URGN?
<0.1% of TipRanks' retail investors hold URGN in their portfolios.
    What is URGN Investor Sentiment?
    URGN’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of URGN in the last 7 days?
      ▼ 1.5% of TipRanks' retail investors changed their holding of URGN in the last 7 days.
        What percentage of retail investors changed their holding of URGN in the last 30 days?
        ▲ 1.1% of TipRanks' retail investors changed their holding of URGN in the last 30 days.
          What is the average age of retail investors who hold URGN?
          The average age of URGN Holders is between 35–55.
            What other stocks have URGN investors also bought?
            URGN Investors also bought VKTX, NIO, JD, CVS, DAL, RIOT, BMY, XYZ, MRK, PDD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              CORCencora
              ANGOAngioDynamics
              BDXBecton Dickinson
              BCRXBioCryst
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis